Targeted Oncology2d
The Targeted Pulse: The Latest FDA Actions Across Cancer Types and Exploring the Efficiency of Remote Pharmacists in Community Oncology
The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.
Targeted Oncology1d
Considering Elacestrant in ESR1+ Breast Cancer After CDK4/6 Inhibition
Paolo Tarantino, MD, PhD, discusses elacestrant as a treatment option for patients with ESR1-mutated metastatic breast cancer in the second line.
Pharm Exec6d
All News
The latest news for pharma industry insiders.
The American Journal of Managed Care5d
Pearl Steinzor
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on datapotamab deruxtecan for patients with HR ...